Presented at the Triological Society Combined Sections Meeting, Orlando, Florida, U.S.A., February 4–7, 2010. Winner of the 2010 Triological Society Paul Holinger Resident Research Award.
Head and Neck
Version of Record online: 17 MAY 2010
Copyright © 2010 The American Laryngological, Rhinological, and Otological Society, Inc.
Volume 120, Issue 6, pages 1166–1172, June 2010
How to Cite
Shuman, A. G., Duffy, S. A., Ronis, D. L., Garetz, S. L., McLean, S. A., Fowler, K. E. and Terrell, J. E. (2010), Predictors of poor sleep quality among head and neck cancer patients. The Laryngoscope, 120: 1166–1172. doi: 10.1002/lary.20924
This work was supported by the National Institutes of Health through the University of Michigan's Head and Neck Specialized Program of Research Excellence grant (P50 CA97248). The authors have no other funding, financial relationships, or conflicts of interest to disclose.
- Issue online: 21 MAY 2010
- Version of Record online: 17 MAY 2010
- Manuscript Accepted: 4 MAR 2010
- Manuscript Revised: 1 MAR 2010
- Manuscript Received: 1 DEC 2009
- Head and neck cancer;
- Level of Evidence: 2c
The objective of this study was to determine the predictors of sleep quality among head and neck cancer patients 1 year after diagnosis.
This was a prospective, multisite cohort study of head and neck cancer patients (N = 457).
Patients were surveyed at baseline and 1 year after diagnosis. Chart audits were also conducted. The dependent variable was a self-assessed sleep score 1 year after diagnosis. The independent variables were a 1 year pain score, xerostomia, treatment received (radiation, chemotherapy, and/or surgery), presence of a feeding tube and/or tracheotomy, tumor site and stage, comorbidities, depression, smoking, problem drinking, age, and sex.
Both baseline (67.1) and 1-year postdiagnosis (69.3) sleep scores were slightly lower than population means (72). Multivariate analyses showed that pain, xerostomia, depression, presence of a tracheotomy tube, comorbidities, and younger age were statistically significant predictors of poor sleep 1 year after diagnosis of head and neck cancer (P < .05). Smoking, problem drinking, and female sex were marginally significant (P < .09). Type of treatment (surgery, radiation and/or chemotherapy), primary tumor site, and cancer stage were not significantly associated with 1-year sleep scores.
Many factors adversely affecting sleep in head and neck cancer patients are potentially modifiable and appear to contribute to decreased quality of life. Strategies to reduce pain, xerostomia, depression, smoking, and problem drinking may be warranted, not only for their own inherent value, but also for improvement of sleep and the enhancement of quality of life. Laryngoscope, 2010